Nucleic acid amplification testing (NAAT) is trusted to deliver high sensitivity and specificity with each result. However, not all molecular tests are equal—complex manual steps are subject to human error and may limit the ability of laboratories to meet surges in demand. In light of the current shortage of skilled laboratory workers and efforts to consolidate in healthcare, elevating efficiency is essential—eliminating time-consuming manual processes, reducing the opportunity for error, lowering cost, and allowing for more predictable result delivery.12-14
Today, the increased availability of high-throughput fully automated molecular systems and well-designed, easy-to-use assays makes molecular testing more accessible. Additionally, gains in throughput and automation on these systems can also be applied to LDTs for increased flexibility in times of crisis.